Jan
28
2020
On demand

Collaborative development of a new fill/finish instrument

The lack of a robust, scalable solution for autologous cell therapy fill-finish has ensured that this vital final step in the bioprocess remains fraught with challenges. Typically, industry has been forced to resort to a suboptimal, manual syringe and manifold approach.

This webinar examine the very latest technology and its capability to deliver the commercially ready, small volume fill-finish instrument required by industry. In addition, a diverse panel offering expert drug developer, CMO/CRO and tool provider perspectives explore future partnering models and methods for accelerating the novel product development process and further advancing the cell and gene therapy industry.

  • Overview of a typical process for developing a new off-the-shelf instrument, including opportunities for user input
  • Examples of key learnings from user feedback that had important implications in the development of a new instrument designed for use in fill/finish and other wash/concentrate/formulate/aliquot applications
  • Importance of tool provider and customer early data generation
  • Tool provider and contract manufacturer perspectives on the most effective ways to collaborate during instrument development and opportunities for the field to improve


Alaina Schlinker
Senior Manager, Cell Therapy Application Support at Fresenius Kabi
Chris Wegener
Director, Cell Therapy R&D
David Smith
Senior Biomedical Engineer at Hitachi Chemical Advanced Therapeutics Solutions
Jahid Hasan
Senior Process Development Scientist at Cell and Gene Therapy Catapult

SPEAKERS

Alaina Schlinker
Senior Manager, Cell Therapy Application Support at Fresenius Kabi
Chris Wegener
Director, Cell Therapy R&D
David Smith
Senior Biomedical Engineer at Hitachi Chemical Advanced Therapeutics Solutions
Jahid Hasan
Senior Process Development Scientist at Cell and Gene Therapy Catapult

You might also like

Thinking translational: Things to consider in CAR T cell research workflows

S Rösch, PhD
Saskia Rösch, PhD
Saskia Rösch, PhD
Global Product Manager at Miltenyi Biotec
22 Jun 2022
35
Days
0
Hrs
21
Min
Register

Optimizing mRNA purification conditions by using a Design of Experiments...

J England
Jenny England
Jenny England
Application Scientist and Innovation Leader at Thermo Fisher Scientific
14 Jun 2022
27
Days
0
Hrs
21
Min
Register

Monitoring of circulating CAR T cells

A Graband,
D Hünecke,
D Bremm
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
Dr. Sabine Hünecke
Dr. Sabine Hünecke
Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
Dr. Melanie Bremm
Dr. Melanie Bremm
Deputy Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
31 May 2022
13
Days
0
Hrs
21
Min
Register

Improving T cell therapy manufacturing processes with automation and...

E Zynda, PhD
Evan Zynda, PhD
Evan Zynda, PhD
Staff Scientist, Cell Biology at Thermo Fisher Scientific
26 May 2022
8
Days
0
Hrs
21
Min
Register

Streamlined workflow solutions for cell and gene therapy analytics

A Graband
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
24 May 2022
6
Days
0
Hrs
21
Min
Register